去年还后悔上市,今年股价涨超17倍 对话北海康成董事长薛群:“罕见病第一股”是煎熬炼成的

每日经济新闻
Aug 22

港股创新药板块几度升温,创新药企业突破“千亿市值”的神话时不时传出。其中,有一支市值仅约10亿港元的小盘股,跑出了别人望尘莫及的速度——今年以来,北海康成的股价涨幅已经超过1700%。  从今年5月首款自研罕见病药物获批,到8月中旬公司所有产品通过商保创新药目录初审、获得1亿元战略投资,股价连跌3年的“罕见病第一股”,终于火了一把。  “如果有人在去年年底问我上市的选择对不对,我可能觉得有争议,但...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10